Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1848-1854

  Garcia Villalón, Angel Luis ^a   Garcia, José Luis ^a   Fernández, Nuria ^a   Monge, Luis ^a   Gómez, Bernardino ^a   Diéguez, Godofredo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

N(G) nitro L arginine methyl ester (L NAME); Rabbit arteries; V1 and V2 vasopressin antagonist; V1 vasopressin antagonist; Vasoconstriction

Indexed keywords

DESMOPRESSIN; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1 RECEPTOR;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; EAR ARTERY; FEMALE; MALE; MESENTERIC ARTERY; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; PULMONARY ARTERY; RABBIT; RENAL ARTERY; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0029998212     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15613.x     Document Type: Article

References (24)

1. 2 vasopressin-receptor mediated renal vasodilation. J. Cardiovasc. Pharmacol., 23, 331-336.
2. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-58.
3. BOCKMAN, C.S., JEFFRIES, W.B., PETTINGER, W.A. & ABEL, P.W. (1993). Endothelium, vasopressin receptors and resistance to DOCA-salt hypertension. Am. J. Physiol., 265, H15-H21.
4. COWLEY, A.W. & LIARD, J-F. (1987). Cardiovascular actions of vasopressin. In Vasopressin: Principles and Properties. ed. Gash, D.M. & Boer, G.J. pp. 389-433. New York: Plenum.
5. FERNANDEZ, N , GARCIA, JL., GARCÍA-VillalóN, A.L., MONGE, L.. GOMEZ, B. & DIÉGUEZ, G. (1993). Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Br. J. Pharmacol., 110, 428-434.
6. GARCÍA. J.L., FERNANDEZ, N., GARCÍA-VillalóN, A.L., MONGE, L., GÓMEZ. B. & DIÉGUEZ, G. (1992). Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulation. Br. J. Pharmacol., 106, 563-567.
7. G-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br. J. Pharmacol., 102, 65-72.
8. 1) receptor characteristics in rat aortic smooth muscle cells. Am. J. Physiol., 261, H1927-H1936.
9. HEYDRICKX, G.R., BOETTCHER, D.H. & VATNER, S.F. (1976). Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am. J. Physiol., 231, 1579-1587.
10. JARD, S., GAILLARD, R.C., GUILLON, G., MARIE, J., SCHOENEN-BERG, P., MULLER, A.F., MANNING, M. & SAWYER, W.H. (1986). Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol. Pharmacol., 30, 171-177.
11. KATUSIC, Z.S. (1992). Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin. Am. J. Physiol., 262, H1557-H1562.
12. KATUSIC, Z.S., SHEPHERD, J.T. & VANHOUTTE, P.M. (1984). Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ. Res., 55, 575-579.
13. LIARD, J.F., DÉRIAZ, O., SCHELLING, P. & THIBONNIER, M. (1982). Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs. Am. J. Physiol., 243, H663-H669.
14. LLUCH, S., CONDE, M.V., DIÉGUEZ, G., LÔPEZ DE PABLO, A.L., GONZALEZ, M.C., ESTRADA, C. & GÓMEZ, B. (1984). Evidence for the direct effect of vasopressin on human and goat cerebral arteries. J. Pharmacol. Exp. Ther., 228, 749-755.
15. MARTIN DE AGUILERA, E., VILA, J.M., IRURZUN, A. MARTINEZ, M.C., MARTINEZ CUESTA, M.A. & LLUCH, S. (1990). Endothelium-independent contractions of human cerebral arteries in response to vasopressin. Stroke, 21, 1689-1693.
16. MATHER, J.M., ANG, V. & JENKINS, J.S. (1981). Vasopressin in plasma and CSF of patients with subarachnoid hemorrhage. J. Neurol. Neurosurg. Psychiatry, 44, 216-219.
17. MATURI, M.F., MARTIN, S.E., MARKLE, D., MAXWELL, M., BURRUSS, C.R., SPEIR, E., GREENE, R., RO, Y.M., VITALE, D., GREEN, M.V., GOLDSTEIN, S.R., BACHARACH, S.L. & PATTERSON, R.E. (1991). Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circ. Res., 83, 2111-2121.
18. 2 receptors in conscious dogs. Am. J. Physiol., 256, R934-R942.
19. SCHMID, P.O., ABBOUD, P.M., WENDLING, M.G., RAMBERG, E.S., MARK, A.L., HEISTAD, D.D. & ECKSTEIN, J.W. (1974). Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am. J. Physiol., 227, 998-1004.
20. SIGMON, D.H. & BEIERWALTES, W.H. (1993). Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am. J. Physiol., 265, R1276-R1283.
21. TAKAYASU, M., KAJITA, Y., SUZUKI, Y., SHIBUYA, M., SUGITA, K., ISHIKAWA, T. & HIDAKA, H. (1993). Triphasic response of rat intracerebral arterioles to increasing concentrations of vasopressin in vitro. J. Cereb. Blood Flow Metab., 13, 304-309.
22. TURLAPATY, P.D.M.V. & ALTURA, D.M. (1982). Effects of neurohypophyseal peptide hormones on isolated coronary arteries: Role of magnesium ions. Magnesium, 1, 122-128.
23. VANNER, S., JIANG, M-M., BROOKS, V.L. & SURPRENANT, A. (1990). Characterization of vasopressin actions in isolated submucosal arterioles of the intestinal microcirculation. Circ. Res., 67, 1017-1026.
24. WALKER, BR., HAYNES, J. JR., WANG, H.L. & VOELKEL, N.F. (1989). Vasopressin-induced pulmonary vasodilation in rats. Am. J. Physiol., 257, H415-H422.